CorFlow
CorFlow is a biotech company in Baar, Switzerland, founded in 2016. It has raised $60.4M across 3 rounds, most recently a $48.0M Series B in September 2024.
- Headquarters
- Baar
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- corflow.com
- Total Funding
- $60.4M
- Last Round
- $48.0M Series BSep 2024
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.
About
CorFlow Therapeutics AG is a clinical-stage medical device company founded in 2016 and headquartered in Baar, Switzerland, with offices also in Bern. The company is developing the CoFI (Controlled Flow Infusion) System, the first device designed to diagnose and treat microvascular obstruction (MVO) in real time during percutaneous coronary intervention (PCI) for STEMI heart attack patients. MVO — the blockage of small heart blood vessels following a heart attack — affects up to 60% of acute heart attack patients and is the most powerful predictor of re-hospitalization with heart failure. CorFlow's CoFI System received FDA Breakthrough Device Designation in 2019, completed the first-in-human MOCA I trial in 2024, and received FDA approval to proceed with the MOCA II pivotal trial in 2025. In September 2024, the company closed a €44 million (~$48.5M) Series B financing round. CorFlow is CEO-led by Paul Mead and has been backed by angel investors, venture capital, and Swiss government innovation grants.
Summary
It lists 11–50 employees. It has raised $60.4M in total across 3 rounds, most recently a $48.0M Series B round in Sep 2024. Investors include Broadview Ventures, Panakes Partners and Wellington Management.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2024
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/corflow"><img src="https://indexed.vc/api/badge/company/corflow" alt="CorFlow on Indexed.vc" width="260" height="76" /></a>